Indication
Integrase Strand Transfer Inhibitors
1 clinical trial
2 products
Clinical trial
A Phase 2 Randomized Cross-Over Design Study of the Early Metabolic Effects of Dolutegravir or Tenofovir Alafenamide in Healthy VolunteersStatus: Not yet recruiting, Estimated PCD: 2028-01-31
Product
Tenofovir alafenamideProduct
Dolutegravir